Key result
HLA-A02 carriage linked to ~219% higher risk of post-Chikungunya chronic inflammatory joint disease.
Why the study?
Is HLA-A02 carriage associated with progression to post-Chikungunya chronic inflammatory joint disease in CHIKV-infected patients?
Cohort (n=59)
Is HLA-A02 carriage associated with progression to post-Chikungunya chronic inflammatory joint disease in CHIKV-infected patients?
HLA-A02 carriage may be a genetic risk factor for the chronification of Chikungunya virus infection into inflammatory joint disease.
HLA-A02 carriage may signal elevated risk for post-CHIKV chronic joint disease; leaves open its predictive value pending replication in larger cohorts.
BACKGROUND: A substantial proportion of Chikungunya virus (CHIKV)-infected patients progress to post-Chikungunya chronic inflammatory joint disease (pCHIKV-CIJD), yet host genetic determinants of this outcome remain poorly understood. HLA polymorphisms are established risk factors for inflammatory arthropathies, but their role in CHIKV chronification has not been investigated. OBJECTIVES: To explore associations between HLA alleles and progression to pCHIKV-CIJD in a Brazilian cohort. STUDY DESIGN: We performed in silico HLA typing from whole-blood RNA-seq data of 59 CHIKV-infected patients (32 pCHIKV-CIJD and 27 non-pCHIKV-CIJD) using HLAminer. We compared allelic frequencies at two-digit resolution using Fisher's exact test with Bonferroni correction. Additional analyses included supertype classification, heterozygosity scoring, KIR ligand grouping, and logistic regression adjusted for sex, age, and race. RESULTS: HLA-A02 was enriched among pCHIKV-CIJD patients (35.9% vs. 14.8%; OR = 3.19, 95% CI: 1.21-9.21, p = 0.012), remaining nominally significant after covariate adjustment (adjusted OR = 3.57, 95% CI: 1.09-11.73, p = 0.036). The B62 supertype was also more frequent in the chronic group (15.6% vs. 3.7%; OR = 4.76, 95% CI: 0.95-46.73, p = 0.037). Chronic patients showed lower HLA heterozygosity (p = 0.043). However, no association survived the Bonferroni correction. CONCLUSIONS: Our data support a potential association between HLA-A02 carriage and an increased risk of pCHIKV-CIJD. These findings are hypothesis-generating and require validation in larger, independent cohorts.
No takes yet. Share an insight, caveat, or question.
Oliveira et al. (2026) conducted a cohort in Chikungunya virus (CHIKV) infection (n=59). HLA-A02 carriage vs. Non-carriage was evaluated on Progression to post-Chikungunya chronic inflammatory joint disease (pCHIKV-CIJD) (OR 3.19, 95% CI 1.21-9.21, p=0.012). HLA-A02 carriage was associated with an increased risk of post-Chikungunya chronic inflammatory joint disease (OR 3.19; 95% CI 1.21-9.21; p=0.012), though it did not survive Bonferroni correction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: